DiagnoCure retains JMP Securities
August 24, 2010 by stephenkilmer · Leave a Comment
DiagnoCure (TSX:CUR) has retained financial advisors JMP Securities to assist in determining the best option to drive the growth of its U.S.-based subsidiary, DiagnoCure Oncology Laboratories. “We are very excited to be partnering with JMP, and we are confident that their expertise will help us determine the most effective method to roll out our colorectal [...]
Listen to BioTuesdays 
